Clinical Trials Logo

Drug Misuse clinical trials

View clinical trials related to Drug Misuse.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06454565 Completed - Drug Use Clinical Trials

Effects of Traditional Martial Arts, Open and Locked Exercise on the Physical and Mental Health of Drug Users

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to discuss the efficacy of Chinese traditional martial arts in reducing drug addiction and improving the physical and mental health of drug addicts.

NCT ID: NCT06317415 Completed - Antibiotic Use Clinical Trials

Intervention on Non-prescription Antibiotic Use Among the Public

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to test the effectiveness of health education int led by community health workers for non-prescription antibiotic use among the public. In this two arm cluster randomised trial, In this two-arm cluster randomized controlled trial, 22 communities were randomly allocated in a 1:1 ratio to intervention and control groups. In the intervention group, family doctors will conduct WeChat-based health education on responsible use of antibiotic for the participants. In the control group, only routine public health education will be provided without any involvement in antibiotic use. The primary outcome is the incidence of antibiotic use without prescription in the past month.

NCT ID: NCT06097676 Completed - Abuse Potential Clinical Trials

An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Users

Start date: September 28, 2021
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the abuse potential of gabapentin enacarbil in healthy adult, non-dependent, recreational drug users.

NCT ID: NCT03512418 Completed - HIV Infections Clinical Trials

Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users (PrEPSteps)

PrEPSteps
Start date: June 20, 2019
Phase: Phase 3
Study type: Interventional

This study will deploy a novel, personalized, smartphone-based intervention (PrEPSteps) that responds to real-time PrEP adherence and nonadherence detected through the use of a digital pill. The PrEPSteps intervention will be developed and refined through a series of focus groups. Participants will be screened at the Screening Visit, and, if eligible, will then begin using the digital pill system at Study Visit 1 for 2 weeks. At Study Visit 2, participants will undergo randomization to using either PrEPSteps + the digital pill, or the digital pill alone to measure PrEP adherence, for 90 days. Participants will then complete 3 monthly study visits (Study Visits 3-5) where the investigators will assess digital pill adherence, conduct manual pill counts, obtain dried blood spots to confirm adherence, provide substance use disorder counseling, and obtain urine drug screens. At Study Visit 5, the investigators will conduct a semi-structured qualitative interview with participants in the PrEPsteps arm, which will be grounded in the Technology Acceptance Model, in order to understand the user response to PrEPSteps and the digital pill. All participants will complete the final follow-up assessment 3 months after Study Visit 5 (Study Visit 6).